Targeting of somatic hypermutation

Nature Reviews Immunology

Volumn 6, Issue 8, 2006, Pages 573-583

  Odegard, Valerie H ^a   Schatz, David G ^b  

^a VaxInnate Corporation   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE DEAMINASE; DOUBLE STRANDED DNA; HISTONE; HISTONE H2B; IMMUNOGLOBULIN;

B CELL LYMPHOMA; BASE PAIRING; CARCINOGENESIS; CELL DIVISION; CHROMATIN STRUCTURE; DNA MODIFICATION; DNA REPLICATION; DNA STRAND BREAKAGE; DNA SUPERCOILING; EXCISION REPAIR; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENE TARGETING; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; GENOME; GENOMICS; HUMAN; MISMATCH REPAIR; MOLECULAR DYNAMICS; MOLECULAR GENETICS; MUTATION RATE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL; SOMATIC HYPERMUTATION; STEREOISOMERISM; TRANSGENE;

ANIMALS; CYTIDINE DEAMINASE; ENHANCER ELEMENTS (GENETICS); HISTONES; HUMANS; IMMUNOGLOBULINS; LYMPHOMA, B-CELL; MODELS, GENETIC; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 33746574474     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1896     Document Type: Review

References (121)

1. Goossens, T., Klein, U. & Kuppers, R. Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc. Natl Acad. Sci. USA 95, 2463-2468 (1998).
2. Rogozin, I. B. & Diaz, M. Cutting edge: DGYW/WRCH is a better predictor of mutability at G:C bases in Ig hypermutation than the widely accepted RGYW/WRCY motif and probably reflects a two-step activation-induced cytidine deaminase-triggered process. J. Immunol. 172, 3382-3384 (2004).
3. Storb, U. et al. Cis-acting sequences that affect somatic hypermutation of Ig genes. Immunol. Rev. 162, 153-160 (1998).
4. Fukita, Y, Jacobs, H. & Rajewsky, K. Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity 9, 105-114 (1998).
5. Bachl, J., Carlson, C., Gray-Schopfer, V., Dessing, M. & Olsson, C. Increased transcription levels induce higher mutation rates in a hypermutating cell line. J. Immunol. 166, 5051-5057 (2001).
6. Rada, C. & Milstein, C. The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially. EMBO J. 20, 4570-4576 (2001).
7. Peters, A. & Storb, U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4, 57-65 (1996). Duplication of the Igκ promoter immediately upstream of the Cκ region targeted SHM to this region in the context of an Igκ transgene. In light of this finding, a transcription-coupled model for SHM was first proposed.
8. Shen, H. M., Ratnam, S. & Storb, U. Targeting of the activation-induced cytosine deaminase is strongly influenced by the sequence and structure of the targeted DNA. Mol. Cell. Biol. 25, 10815-10821 (2005).
9. Longerich, S., Tanaka, A., Bozek, G., Nicolae, D. & Storb, U. The very 5′ end and the constant region of Ig genes are spared from somatic mutation because AID does not access these regions. J. Exp. Med. 202, 1443-1454 (2005).
10. Muramatsu, M. et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563 (2000).
11. Revy, P. et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102, 565-575 (2000).
12. Arakawa, H., Hauschild, J. & Buerstedde, J. M. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science 295, 1301-1306 (2002).
13. Harris, R. S., Sale, J. E., Petersen-Mahrt, S. K. & Neuberger, M. S. AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Curr. Biol. 12, 435-438 (2002).
14. Okazaki, I. M. et al. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 197, 1173-1181 (2003). Transgenic mice designed to express AID ubiquitously develop T-cell lymphomas that have mutations in the genes encoding the T-cell receptor and MYC. Therefore, dysregulated expression of AID can lead to malignancy in vivo.
15. Petersen-Mahrt, S. K., Harris, R. S. & Neuberger, M. S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418, 99-103 (2002).
16. Yoshikawa, K. et al. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296, 2033-2036 (2002).
17. Shinkura, R. et al. Separate domains of AID are required for somatic hypermutation and class-switch recombination. Nature Immunol. 5, 707-712 (2004).
18. Ta, V. T. et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nature Immunol. 4, 843-848 (2003).
19. Barreto, V., Reina-San-Martin, B., Ramiro, A. R., McBride, K. M. & Nussenzweig, M. C. C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol. Cell 12, 501-508 (2003).
20. Ito, S. et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc. Natl Acad. Sci. USA 101, 1975-1980 (2004).
21. Brar, S. S., Watson, M. & Diaz, M. Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. J. Biol. Chem. 279, 26395-26401 (2004).
22. McBride, K. M., Barreto, V., Ramiro, A. R., Stavropoulos, P. & Nussenzweig, M. C. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J. Exp. Med. 199, 1235-1244 (2004).
23. Chaudhuri, J., Khuong, C. & Alt, F. W. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature 430, 992-998 (2004).
24. Pasqualucci, L., Kitaura, Y., Gu, H. & Dalla-Favera, R. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc. Natl Acad. Sci. USA 103, 395-400 (2006).
25. Basu, U. et al. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 438, 508-511 (2005).
26. Muramatsu, M. et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274, 18470-18476 (1999).
27. Chaudhuri, J. et al. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422, 726-730 (2003). This elegant study shows that transcription can target AID activity to dsDNA by generating the ssDNA substrate preferred by this enzyme, providing a mechanistic link between transcription and SHM.
28. Pham, P., Bransteitter, R., Petruska, J. & Goodman, M. F. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 424, 103-107 (2003). This group shows that AID targets WRC motifs in ssDNA, introduces multiple mutations in one molecule of DNA (and thereby seems to function processively), and prefers to act on the non-transcribed strand of DNA that is exposed during transcription. Together, these findings provide a biochemical basis for several key features of SHM.
29. Bransteitter, R., Pham, P., Scharff, M. D. & Goodman, M. F. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl Acad. Sci. USA 100, 4102-4107 (2003).
30. Dickerson, S. K., Market, E., Besmer, E. & Papavasiliou, F. N. AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 197, 1291-1296 (2003).
31. Yu, K., Huang, F. T. & Lieber, M. R. DNA substrate length and surrounding sequence affect the activation-induced deaminase activity at cytidine. J. Biol. Chem. 279, 6496-6500 (2004).
32. Ramiro, A. R., Stavropoulos, P., Jankovic, M. & Nussenzweig, M. C. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nature Immunol. 4, 452-456 (2003).
33. Sohail, A., Klapacz, J., Samaranayake, M., Ullah, A. & Bhagwat, A. S. Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations. Nucleic Acids Res. 31, 2990-2994 (2003).
34. Shen, H. M. & Storb, U. Activation-induced cytidine deaminase (AID) can target both DNA strands when the DNA is supercoiled. Proc. Natl Acad. Sci. USA 101, 12997-13002 (2004).
35. Neuberger, M. S., Harris, R. S., Di Noia, J. & Petersen-Mahrt, S. K. Immunity through DNA deamination. Trends Biochem. Sci. 28, 305-312 (2003).
36. Wilson, T. M. et al. MSH2-MSH6 stimulates DNA polymerase η, suggesting a role for A:T mutations in antibody genes. J. Exp. Med. 201, 637-645 (2005).
37. Krokan, H. E., Drablos, F. & Slupphaug, G. Uracil in DNA - occurrence, consequences and repair. Oncogene 21, 8935-8948 (2002).
38. Reynaud, C. A., Aoufouchi, S., Faili, A. & Weill, J. C. What role for AID: mutator, or assembler of the immunoglobulin mutasome? Nature Immunol. 4, 631-638 (2003).
39. Larson, E. D., Cummings, W. J., Bednarski, D. W. & Maizels, N. MRE11/RAD50 cleaves DNA in the AID/ UNG-dependent pathway of immunoglobulin gene diversification. Mol. Cell 20, 367-375 (2005).
40. Rada, C., Jarvis, J. M. & Milstein, C. AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc. Natl Acad. Sci. USA 99, 7003-7008 (2002).
41. Cattoretti, G. et al. Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells. Blood 107, 3967-3975 (2006).
42. Longerich, S., Basu, U., Alt, F. & Storb, U. AID in somatic hypermutation and class switch recombination. Curr. Opin. Immunol. 18, 164-174 (2006).
43. Chaudhuri, J. & Alt, F. W. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nature Rev. Immunol. 4, 541-552 (2004).
44. Papavasiliou, F. N. & Schatz, D. G. Cell-cycle-regulated DNA double-stranded breaks in somatic hypermutation of immunoglobulin genes. Nature 408, 216-221 (2000).
45. Bross, L. et al. DNA double-strand breaks in immunoglobulin genes undergoing somatic hypermutation. Immunity 13, 589-597 (2000).
46. Papavasiliou, F. N. & Schatz, D. G. The activation-induced deaminase functions in a postcleavage step of the somatic hypermutation process. J. Exp. Med. 195, 1193-1198 (2002).
47. Bross, L., Muramatsu, M., Kinoshita, K., Honjo, T. & Jacobs, H. DNA double-strand breaks: prior to but not sufficient in targeting hypermutation. J. Exp. Med. 195, 1187-1192 (2002).
48. Zan, H., Wu, X., Komori, A., Holloman, W. K. & Casali, P. AID-dependent generation of resected double-strand DNA breaks and recruitment of Rad52/Rad51 in somatic hypermutation. Immunity 18, 727-738 (2003).
49. Haber, J. E. Hypermutation: give us a break. Nature Immunol. 2, 902-903 (2001).
50. Kong, Q. & Maizels, N. DNA breaks in hypermutating immunoglobulin genes: evidence fora break-and-repair pathway of somatic hypermutation. Genetics 158, 369-378 (2001).
51. Redon, C. et al. Histone H2A variants H2AX and H2AZ. Curr. Opin. Genet. Dev. 12, 162-169 (2002).
52. Reina-San-Martin, B. et al. H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J. Exp. Med. 197, 1767-1778 (2003).
53. Odegard, V. H., Kim, S. T., Anderson, S. M., Shlomchik, M. J. & Schatz, D. G. Histone modifications associated with somatic hypermutation. Immunity 23, 101-110 (2005).
54. Woo, C. J., Martin, A. & Scharff, M. D. Induction of somatic hypermutation is associated with modifications in immunoglobulin variable region chromatin. Immunity 19, 479-489 (2003).
55. Rada, C., Di Noia, J. M. & Neuberger, M. S. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol. Cell 16, 163-171 (2004).
56. Di Noia, J. & Neuberger, M. S. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419, 43-48 (2002).
57. Schrader, C. E., Linehan, E. K., Mochegova, S. N., Woodland, R. T. & Stavnezer, J. Inducible DNA breaks in Ig S regions are dependent on AID and UNC. J. Exp. Med. 202, 561-568 (2005).
58. Pasqualucci, L. et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl Acad. Sci. USA 95, 11816-11821 (1998).
59. Shen, H. M., Peters, A., Baron, B., Zhu, X. & Storb, U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280, 1750-1752 (1998). This paper marks the first time that a gene other than the immunoglobulin genes was shown to be a target of SHM in normal B cells.
60. Muschen, M. et al. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J. Exp. Med. 192, 1 833-1 840 (2000).
61. Pasqualucci, L. et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341-346 (2001). Multiple proto-oncogenes were found to contain SHM-like mutations in diffuse large B-cell lymphomas, pinpointing a possible origin for genomic instability during certain types of B-cell tumorigenesis.
62. Gordon, M. S., Kanegai, C. M., Doerr, J. R. & Wall, R. Somatic hypermutation of the B cell receptor genes B29 (Igβ, CD79b) and mb1 (Igα, CD79a). Proc. Natl Acad. Sci. USA 100, 4126-4131 (2003).
63. Muto, T. et al. Negative regulation of activation-induced cytidine deaminase in B cells. Proc. Natl Acad. Sci. USA 103, 2752-2757 (2006).
64. Hori, M., Qi, C. F., Torrey, T. A., Huppi, K. & Morse, H. C.. The Bcl6 locus is not mutated in mouse B-cell lineage lymphomas. Leuk. Res. 26, 739-743 (2002).
65. Neuberger, M. S. et al. Monitoring and interpreting the intrinsic features of somatic hypermutation. Immunol. Rev. 162, 107-116 (1998).
66. Ramiro, A. R. et al. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440, 105-109 (2006).
67. Ramiro, A. R. et al. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118, 431-438 (2004).
68. Franco, S. et al. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol. Cell 21, 201-214 (2006).
69. Shen, H. M., Michael, N., Kim, N. & Storb, U. The TATA binding protein, c-Myc and survivin genes are not somatically hypermutated, while Ig and BCL6 genes are hypermutated in human memory B cells. Int. Immunol. 12, 1085-1093 (2000).
70. Hesslein, D. G. & Schatz, D. G. Factors and forces controlling V(D)J recombination. Adv. Immunol. 78, 169-232 (2001).
71. O'Brien, R. L., Brinster, R. L. & Storb, U. Somatic hypermutation of an immunoglobulin transgene in κ transgenic mice. Nature 326, 405-409 (1987).
72. Sharpe, M. J., Milstein, C., Jarvis, J. M. & Neuberger, M. S. Somatic hypermutation of immunoglobulin κ may depend on sequences 3′ of Cκ and occurs on passenger transgenes. EMBO J. 10, 2139-2145 (1991).
73. Klotz, E. L. & Storb, U. Somatic hypermutation of a λ 2 transgene under the control of the λ enhancer or the heavy chain intron enhancer. J. Immunol. 157, 4458-4463 (1996).
74. Kong, Q., Zhao, L., Subbaiah, S. & Maizels, N. A λ 3′ enhancer drives active and untemplated somatic hypermutation of a λ 1 transgene. J. Immunol. 161, 294-301 (1998).
75. Giusti, A. M. & Manser, T. Hypermutation is observed only in antibody H chain V region transgenes that have recombined with endogenous immunoglobulin H DNA: implications for the location of cis-acting elements required for somatic mutation. J. Exp. Med. 177, 797-809 (1993).
76. Tumas-Brundage, K. & Manser, T. The transcriptional promoter regulates hypermutation of the antibody heavy chain locus. J. Exp. Med. 185, 239-250 (1997).
77. Hengstschlager, M., Williams, M. & Maizels, N. A λ 1 transgene under the control of a heavy chain promoter and enhancer does not undergo somatic hypermutation. Eur. J. Immunol. 24, 1649-1656 (1994).
78. Sohn, J., Gerstein, R. M., Hsieh, C. L., Lemer, M. & Selsing, E. Somatic hypermutation of an immunoglobulin μ heavy chain transgene. J. Exp. Med. 177, 493-504 (1993).
79. Yelamos, J. et al. Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature 376, 225-229 (1995). This group shows that the rearranged variable region is not required for targeting SHM to an Igκ transgene. This study initiated the search for cis-acting elements that target SHM in transgenic mice.
80. Michael, N. et al. Effects of sequence and structure on the hypermutability of immunoglobulin genes. Immunity 16, 123-134 (2002).
81. Betz, A. G. et al. Elements regulating somatic hypermutation of an immunoglobulin κ gene: critical role for the intron enhancer/matrix attachment region. Cell 77, 239-248 (1994). This pivotal study shows that the Igκ intronic enhancer is required for targeting SHM to an Igκ transgene and that this activity is separate from the enhancer's role in transcription. In addition, the Igκ 3′ enhancer is also required for SHM of the transgene, but this function is most probably due to this enhancer's role in stimulating transcription. Together, these data lead to a model in which the SHM machinery is specifically recruited by immunoglobulin enhancers to immunoglobulin loci.
82. Queen, C. & Stafford, J. Fine mapping of an immunoglobulin gene activator. Mol. Cell. Biol. 4, 1042-1049 (1984).
83. Meyer, K. B. & Neuberger, M. S. The immunoglobulin κ locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region. EMBO J. 8, 1959-1964 (1989).
84. Goyenechea, B. et al. Cells strongly expressing Igκ transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers. EMBO J. 16, 3987-3994 (1997).
85. Klix, N. et al. Multiple sequences from downstream of the JK cluster can combine to recruit somatic hypermutation to a heterologous, upstream mutation domain. Eur. J. Immunol. 28, 317-326 (1998).
86. Jolly, C. J. & Neuberger, M. S. Somatic hypermutation of immunoglobulin κ transgenes: association of mutability with demethylation. Immunol. Cell. Biol. 79, 18-22 (2001).
87. Michael, N. et al. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 19, 235-242 (2003).
88. Gorman, J. R. et al. The Igκ enhancer influences the ratio of Igκ versus Igλ B lymphocytes. Immunity 5, 241-252 (1996).
89. κ function in stage- and lineage-specific rearrangement and somatic hypermutation. Immunity 8, 743-750 (1998). Using mice lacking the Igκ 3′ enhancer, this study shows that the Igκ 3′ enhancer is not essential for transcription or mutation of the endogenous Igκ locus; these results are different from those obtained from Igκ transgenes.
90. Inlay, M. A. et al. Roles of the immunoglobulin κ light chain intronic and 3′ enhancers in Igκ somatic hypermutation. J. Immunol. 177, 1146-1151 (2006).
91. Ronai, D., Iglesias-Ussel, M. D., Fan, M., Shulman, M. J. & Scharff, M. D. Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells. Proc. Natl Acad. Sci. USA 102, 11829-11834 (2005).
92. Perlot, T, Alt, F. W., Bassing, C. H., Suh, H. & Pinaud, E. Elucidation of IgH intronic enhancer functions via germ-line deletion. Proc. Natl Acad. Sci. USA 102, 14362-14367 (2005).
93. Tumas-Brundage, K. M., Vora, K. A. & Manser, T. Evaluation of the role of the 3′α heavy chain enhancer [3′α E(hs1, 2)] in Vh gene somatic hypermutation. Mol. Immunol. 34, 367-378 (1997).
94. Liu, Z. M. et al. Chromatin structural analyses of the mouse Igκ gene locus reveal new hypersensitive sites specifying a transcriptional silencer and enhancer. J. Biol. Chem. 277, 32640-32649 (2002).
95. Schlissel, M. S. Regulation of activation and recombination of the murine Igκ. locus. Immunol. Rev. 200, 215-223 (2004).
96. Staudt, L. M. & Lenardo, M. J. Immunoglobulin gene transcription. Annu. Rev. Immunol. 9, 373-398 (1991).
97. Henderson, A. & Calame, K. Transcriptional regulation during B cell development. Annu. Rev. Immunol. 16, 163-200 (1998).
98. Henderson, A. J. & Calame, K. L. Lessons in transcriptional regulation learned from studies on immunoglobulin genes. Crit. Rev. Eukaryot. Gene Expr. 5, 255-280 (1995).
99. Bain, G. & Murre, C. The role of E-proteins in B- and T-lymphocyte development. Semin. Immunol. 10, 143-153 (1998).
100. Kotani, A. et al. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression. Proc. Nat. Acad. Sci. USA 102, 4506-4511 (2005).
101. Conlon, T. M. & Meyer, K. B. The chicken Ig light chain 3′-enhancer is essential for gene expression and regulates gene conversion via the transcription factor E2A. Eur. J. Immunol. 36, 139-148 (2006).
102. Kurdistani, S. K. & Grunstein, M. Histone acetylation and deacetylation in yeast. Nature Rev. Mol. Cell Biol. 4, 276-284 (2003).
103. Nambu, Y. et al. Transcription-coupled events associating with immunoglobulin switch region chromatin. Science 302, 2137-2140 (2003).
104. Li, Z., Luo, Z. & Scharff, M. D. Differential regulation of histone acetylation and generation of mutations in switch regions is associated with Ig class switching. Proc. Natl Acad. Sci. USA 101, 15428-15433 (2004).
105. Kuo, M. H., vom Baur, E., Struhl, K. & Allis, C. D. Gcn4 activator targets Gcn5 histone acetyltransferase to specific promoters independently of transcription. Mol. Cell 6, 1309-1320 (2000).
106. Liang, G. et al. Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proc. Natl Acad. Sci. USA 101, 7357-7362 (2004).
107. Cheung, W. L. et al. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113, 507-517 (2003).
108. Ahn, S. H. et al. Sterile 20 kinase phosphorylates histone H2B at serine 10 during hydrogen peroxide-induced apoptosis in S. cerevisiae. Cell 120, 25-36 (2005).
109. Fernandez-Capetillo, O., Allis, C. D. & Nussenzweig, A. Phosphorylation of histone H2B at DNA double-strand breaks. J. Exp. Med. 199, 1671-1677 (2004).
110. Downs, J. A. et al. Binding of chromatin-modifying activities to phosphorylated histone H2A at DNA damage sites. Mol. Cell 16, 979-990 (2004).
111. Downs, J. A., Lowndes, N. F. & Jackson, S. P. A role for Saccharomyces cerevisiae histone H2A in DNA repair. Nature 408, 1001-1004 (2000).
112. Wang, C. L., Harper, R. A. & Wabl, M. Genome-wide somatic hypermutation. Proc. Natl Acad. Sci. USA 101, 7352-7356 (2004).
113. Parsa, J. Y. et al. AID mutates a non-immunoglobulin transgene independent of chromosomal position. Mol. Immunol. 14 March 2006 (doi: 10.1016/ j.molimm.2006.02.003).
114. Dorner, T. et al. Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J. Immunol. 158, 2779-2789 (1997).
115. Delpy, L., Sirac, C., Le Morvan, C. & Cogne, M. Transcription- dependent somatic hypermutation occurs at similar levels on functional and nonfunctional rearranged IgH alleles. J. Immunol. 173, 1842-1848 (2004).
116. Dunn-Walters, D. K., Dogan, A., Boursier, L., MacDonald, C. M. & Spencer, J. Base-specific sequences that bias somatic hypermutation deduced by analysis of out-of-frame human IgVH genes. J. Immunol. 160, 2360-2364 (1998).
117. Kosak, S. T. et al. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296, 158-162 (2002).
118. Spilianakis, C. G., Lalioti, M. D., Town, T., Lee, G. R. & Flavell, R. A. lnterchromosomal associations between alternatively expressed loci. Nature 435, 637-645 (2005).
119. Johnston, J. M. et al. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes. Eur. J. Immunol. 26, 1058-1062 (1996).
120. Terauchi, A. et al. A pivotal role for DNase I-sensitive regions 3b and/or 4 in the induction of somatic hypermutation of IgH genes. J. Immunol. 167, 811-820 (2001).
121. Morvan, C. L. et al. The immunoglobulin heavy-chain locus hs3b and hs4 3′ enhancers are dispensable for VDJ assembly and somatic hypermutation. Blood 102, 1421-1427 (2003).